Published in Medical Letter on the CDC and FDA, June 21st, 2009
"As the first, multicenter safety registry of its kind to be conducted in the U.S.,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.